BIOGEN INC. (BIIB) › Operating IncomeBIOGEN INC. (BIIB) — Operating IncomeAnnual figures by fiscal year, from SEC filings.2007: $779.77M2008: $1.21B2009: $1.30B2010: $1.25B2011: $1.72B2012: $1.86B2013: $2.52B2014: $3.97B2015: $4.89B2016: $5.15B2017: $5.35B2018: $5.89B2019: $7.04B2020: $4.55B2021: $2.84B$2.84B2007Operating Income (USD)2021Fiscal YearOperating IncomeChange YoY2021$2.84B-37.6%2020$4.55B-35.4%2019$7.04B+19.6%2018$5.89B+10.2%2017$5.35B+3.8%2016$5.15B+5.3%2015$4.89B+23.1%2014$3.97B+57.9%2013$2.52B+35.5%2012$1.86B+7.6%2011$1.72B+38.1%2010$1.25B-3.6%2009$1.30B+6.7%2008$1.21B+55.6%2007$779.77M—Other metrics: RevenueCost of RevenueGross ProfitNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share